Förlängd teckningstid i pågående nyemission

By |2021-10-06T19:29:38+02:00April 7th, 2021|

Förlängd teckningstid i pågående nyemission till 23 april 2021 WED, APR 7, 2021 16:45 CET Styrelsen i FarmPharma AB (publ) har, i enlighet med emissionsvillkoren, beslutat att förlänga tiden för teckning av units i den pågående nyemissionen (såväl med som utan företrädesrätt). Ny slutdag för [...]

Press release

By |2021-10-06T19:34:01+02:00February 26th, 2021|

Press release FRI, FEB 26, 2021 04:00 CET Press release "It is very important to maintain the high tempo of the development of InterferOX and our platform in general,” - comments Irina Zaitseva, CEO of FarmPharma, -” The current pandemic situation provides the evidence [...]

FarmPharma has applied to participate in the EUREKA Eurostar program

By |2021-10-06T19:34:49+02:00February 19th, 2021|

FarmPharma has applied to participate in the EUREKA Eurostar program FRI, FEB 19, 2021 11:30 CET FarmPharma AB (publ) (“FarmPharma” or “Company”), in cooperation with its partners from the Karolinska institute in the framework of an international consortium, has applied for a EUREKA Eurostars grant [...]

FarmPharma signs an agreement with All-Russian Research Institute of Experimental Veterinary Medicine

By |2021-10-06T19:35:44+02:00February 16th, 2021|

FarmPharma signs an agreement with All-Russian Research Institute of Experimental Veterinary Medicine TUE, FEB 16, 2021 10:30 CET Today FarmPharma AB signed a collaboration agreement with Federal Scientific Centre – All-Russian Scientific Research Institute of Experimental Veterinary Medicine named after K. I. Skryabin and Y. [...]

The fourth interferon for the product InterferOX is manufactured

By |2021-01-22T15:36:31+01:00December 14th, 2020|

The fourth interferon for the product InterferOX is manufactured MON, DEC 14, 2020 14:04 CET FarmPharma AB (publ) ("FarmPharma"), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the fourth recombinant cattle interferon, a component of FarmPharma's product InterferOX, is [...]

Record date set for distribution of shares in FarmPharma AB

By |2021-01-22T15:26:35+01:00November 25th, 2020|

Record date set for distribution of shares in FarmPharma AB WED, NOV 25, 2020 10:04 CET The Board of Directors of Double Bond Pharmaceutical International AB (publ) ("DBP") has today decided on a record date for the distribution of shares in FarmPharma AB (publ) ("FarmPharma"). Reconciliation [...]

The third interferon for the product InterferOX is manufactured

By |2021-01-22T15:16:05+01:00August 12th, 2020|

The third interferon for the product InterferOX is manufactured  WED, AUG 12, 2020 13:55 CET FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the third recombinant bovine interferon that is an ingredient in FarmPharma's product InterferOX is manufactured [...]

FarmPharma receives a grant of SEK 300,000

By |2021-01-22T15:08:47+01:00June 12th, 2020|

FarmPharma receives a grant of SEK 300,000 FRI, JUN 12, 2020 10:31 CET FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), have been granted SEK 300,000 by Vinnova in the call "Innovative Startups step 1". The grant will support ongoing [...]

The second interferon for the product InterferOX is manufactured

By |2021-01-22T15:17:15+01:00June 8th, 2020|

The second interferon for the product InterferOX is manufactured MON, JUN 8, 2020 09:31 CET FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the second recombinant bovine interferon, which is the second component of FarmPharma's product [...]